ISP: Nuclear Medicine (PET/CT and Whole-Body MR Imaging)
Sunday, Nov. 28, 10:45 AM - 12:15 PM
In this multi-modality ISP session, researchers are sharing a host of studies related to MRI and PET/CT. The session is opening with a keynote that considers when to use PET/CT and whole-body MRI and how to determine the right modality. Other presenters are reporting on the first clinical experience with PET/MRI and comparing body PET/CT and whole-body MRI for a variety of specific indications including staging of Hodgkin’s and non-Hodgkin’s lymphoma and breast cancer and assessment of recurrent prostate cancer.
- Homer Aquino Macapinlac, MD, professor, nuclear medicine MD Anderson Cancer Center in Houston;
- Patrick Veit-Haibach, MD, department of nuclear medicine, University Hospital in Zurich, Switzerland; and
- Gustav Von Schulthess, MD, PhD, director, nuclear medicine, University Hospital in Zurich, Switzerland.